Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity
炎症驱动的 T 细胞反应及其对宿主免疫的二分效应
基本信息
- 批准号:10593467
- 负责人:
- 金额:$ 16.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-01 至 2022-08-11
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY / ABSTRACT
The memory CD8 T cell compartment can be activated by inflammatory cues even in the absence of a T cell
receptor signal. This process is referred to as bystander-activation of memory T cells and has been observed
following different infections. The contribution of these cells to host immunity was poorly understood until we
recently reported that bystander-activated memory CD8 T cells play a crucial role in controlling early pathogen
replication following infection. We demonstrated that bystander-activated memory CD8 T cells express
granzyme B and can directly kill target cells in a TCR-independent, innate-like fashion. In stark contrast to their
beneficial effect for host immunity following infection, our most recent data provide strong evidence that these
bystander-activated T cells decrease antigen availability following vaccination by eliminating antigen-
presenting cells.
We propose to test the hypothesis that bystander-activated memory CD8 T cells play a fundamental and thus
far unappreciated role in directly controlling the size of the cellular and humoral immune response following
vaccination. We will determine which memory T cell subsets are capable of becoming bystander-activated,
identify how bystander-activated T cells affect subsequent adaptive immune responses and define the
mechanisms that lead to decreased antigen availability following vaccination. We will use a mouse model
system to define the underlying mechanisms of target cell elimination and primary human T cells ex vivo to
ensure direct relevance for human health.
This proposal is highly significant because addressing the role of bystander-activated memory T cells in a
vaccine context is one of the most significant and pressing cellular immunology research topics due to the inability
to achieve effective immunity by vaccination in select populations at risk for and most susceptible to infections.
This proposal is highly innovative because we identified NKG2D as a key molecule in this process and
engineered a novel antagonist designed to enhance vaccine efficacy by inhibiting bystander-activated CD8 T
cell function. Our proposed experiments clearly define the impact of bystander-activation on subsequent
immune responses and to provide a new strategy for enhancing vaccine efficacy.
项目总结/摘要
即使在没有T细胞的情况下,记忆性CD 8 T细胞区室也可以被炎症因子激活
受体信号这个过程被称为记忆T细胞的旁观者激活,
不同的感染。这些细胞对宿主免疫的贡献知之甚少,直到我们
最近报道,旁观者激活的记忆CD 8 T细胞在控制早期病原体中起着至关重要的作用,
感染后复制。我们证明了旁观者激活的记忆性CD 8 T细胞表达
颗粒酶B,并且可以以TCR非依赖性的先天性方式直接杀死靶细胞。与他们的
对于感染后宿主免疫的有益作用,我们最近的数据提供了强有力的证据,
旁观者激活的T细胞通过消除抗原降低疫苗接种后的抗原可用性,
递呈细胞。
我们建议测试这一假设,即旁观者激活的记忆CD 8 T细胞发挥了基本作用,
在直接控制细胞和体液免疫反应的大小方面,
预防针我们将确定哪些记忆T细胞亚群能够被旁观者激活,
确定旁观者激活的T细胞如何影响随后的适应性免疫应答,并确定
导致疫苗接种后抗原可用性降低的机制。我们将使用一个小鼠模型
系统来定义靶细胞消除和原代人T细胞离体
确保与人类健康直接相关。
这一提议是非常重要的,因为解决旁观者激活的记忆T细胞在免疫系统中的作用是非常重要的。
疫苗背景是最重要和最紧迫的细胞免疫学研究课题之一,
通过在有感染风险和最易感染的特定人群中接种疫苗,实现有效免疫。
该提议具有高度创新性,因为我们确定NKG 2D是该过程中的关键分子,
设计了一种新的拮抗剂,旨在通过抑制旁观者激活的CD 8 T细胞来增强疫苗的效力。
细胞功能我们提出的实验清楚地定义了旁观者激活对随后的影响。
免疫反应,并提供一个新的战略,提高疫苗的效力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin Prlic其他文献
Martin Prlic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin Prlic', 18)}}的其他基金
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
单细胞分析确定人胎盘中的保护性和耐受性免疫细胞群
- 批准号:
9978484 - 财政年份:2020
- 资助金额:
$ 16.68万 - 项目类别:
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
单细胞分析确定人胎盘中的保护性和耐受性免疫细胞群
- 批准号:
10594099 - 财政年份:2020
- 资助金额:
$ 16.68万 - 项目类别:
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
单细胞分析确定人胎盘中的保护性和耐受性免疫细胞群
- 批准号:
10401230 - 财政年份:2020
- 资助金额:
$ 16.68万 - 项目类别:
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity
炎症驱动的 T 细胞反应及其对宿主免疫的二分效应
- 批准号:
10058804 - 财政年份:2016
- 资助金额:
$ 16.68万 - 项目类别:
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity
炎症驱动的 T 细胞反应及其对宿主免疫的二分效应
- 批准号:
10682491 - 财政年份:2016
- 资助金额:
$ 16.68万 - 项目类别:
Paving the Way for a Novel Therapeutic Approach to Combat HIV
为对抗艾滋病毒的新治疗方法铺平道路
- 批准号:
8358310 - 财政年份:2012
- 资助金额:
$ 16.68万 - 项目类别:
CD8 Tau cell contraction and memory formation
CD8 Tau细胞收缩和记忆形成
- 批准号:
7660600 - 财政年份:2009
- 资助金额:
$ 16.68万 - 项目类别:
CD8 Tau cell contraction and memory formation
CD8 Tau细胞收缩和记忆形成
- 批准号:
8282722 - 财政年份:2009
- 资助金额:
$ 16.68万 - 项目类别:
CD8 Tau cell contraction and memory formation
CD8 Tau细胞收缩和记忆形成
- 批准号:
8210398 - 财政年份:2009
- 资助金额:
$ 16.68万 - 项目类别:
相似国自然基金
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国青年学者研究基金项目
基于Cache的远程计时攻击研究
- 批准号:60772082
- 批准年份:2007
- 资助金额:28.0 万元
- 项目类别:面上项目
相似海外基金
Structure-guided optimisation of light-driven microalgae cell factories
光驱动微藻细胞工厂的结构引导优化
- 批准号:
DP240101727 - 财政年份:2024
- 资助金额:
$ 16.68万 - 项目类别:
Discovery Projects
Cost-Effective, AI-driven Automation Technology for Cell Culture Monitoring: Boosting Efficiency and Sustainability in Industrial Biomanufacturing and Streamlining Supply Chains
用于细胞培养监测的经济高效、人工智能驱动的自动化技术:提高工业生物制造的效率和可持续性并简化供应链
- 批准号:
10104748 - 财政年份:2024
- 资助金额:
$ 16.68万 - 项目类别:
Launchpad
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
- 批准号:
480022 - 财政年份:2023
- 资助金额:
$ 16.68万 - 项目类别:
Operating Grants
Chromatin-binding deubiquitinase MYSM1 as a putative drug target for cMYC-driven B cell lymphoma
染色质结合去泛素酶 MYSM1 作为 cMYC 驱动的 B 细胞淋巴瘤的推定药物靶点
- 批准号:
478278 - 财政年份:2023
- 资助金额:
$ 16.68万 - 项目类别:
Operating Grants
TOX-driven CD8 T cell differentiation and dysfunction in tumors
TOX驱动的肿瘤中CD8 T细胞分化和功能障碍
- 批准号:
10586679 - 财政年份:2023
- 资助金额:
$ 16.68万 - 项目类别:
Mechanisms of Pip4k2c and Pip5k1b dependencies in Ras driven squamous cell carcinoma
Ras 驱动的鳞状细胞癌中 Pip4k2c 和 Pip5k1b 依赖性的机制
- 批准号:
10667117 - 财政年份:2023
- 资助金额:
$ 16.68万 - 项目类别:
Leveraging Zika virus driven myeloid cell responses to treat GBM
利用寨卡病毒驱动的骨髓细胞反应来治疗 GBM
- 批准号:
10891973 - 财政年份:2023
- 资助金额:
$ 16.68万 - 项目类别:
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
转移部位对树突状细胞驱动的肿瘤免疫的影响
- 批准号:
10738428 - 财政年份:2023
- 资助金额:
$ 16.68万 - 项目类别:
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
骨髓细胞驱动胰腺可塑性和致癌机制
- 批准号:
10607213 - 财政年份:2023
- 资助金额:
$ 16.68万 - 项目类别:
Model-driven Study of Host Cell Multiscale Dynamics in Viral Infection
病毒感染中宿主细胞多尺度动力学的模型驱动研究
- 批准号:
22KJ1417 - 财政年份:2023
- 资助金额:
$ 16.68万 - 项目类别:
Grant-in-Aid for JSPS Fellows